153 related articles for article (PubMed ID: 38507360)
1. Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
Schrag A; Kostev K
PLoS One; 2024; 19(3):e0299985. PubMed ID: 38507360
[TBL] [Abstract][Full Text] [Related]
2. The association between antihypertensive therapy and the incidence of Parkinson's disease in patients followed in general practices in Germany
.
Warda A; Reese JP; Tanislav C; Kostev K
Int J Clin Pharmacol Ther; 2019 Oct; 57(10):483-488. PubMed ID: 31426904
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: impact of drug class on adherence to antihypertensives.
Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
Lee YC; Lin CH; Wu RM; Lin JW; Chang CH; Lai MS
PLoS One; 2014; 9(6):e98961. PubMed ID: 24910980
[TBL] [Abstract][Full Text] [Related]
7. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
8. Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.
Bezabih YM; Bezabih A; Alamneh E; Peterson GM; Bezabhe W
BMC Infect Dis; 2021 Jun; 21(1):527. PubMed ID: 34090358
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
10. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.
Liampas I; Hatzimanolis A; Siokas V; Yannakoulia M; Kosmidis MH; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
J Alzheimers Dis; 2022; 89(2):709-719. PubMed ID: 35912747
[TBL] [Abstract][Full Text] [Related]
13. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive Use and the Risk of Cataract in Patients with Hypertension: A Nationwide Case-control Study.
Yang HL; Byun SJ; Park S; Lee SH; Park SJ; Jung SY
Ophthalmic Epidemiol; 2023 Oct; 30(5):499-508. PubMed ID: 36369827
[TBL] [Abstract][Full Text] [Related]
15. Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease.
Visanji NP; Madan P; Lacoste AMB; Buleje I; Han Y; Spangler S; Kalia LV; Hensley Alford S; Marras C
Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):201-209. PubMed ID: 33219601
[TBL] [Abstract][Full Text] [Related]
16. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.
Rezel-Potts E; Douiri A; Chowienczyk PJ; Gulliford MC
Br J Clin Pharmacol; 2021 Dec; 87(12):4598-4607. PubMed ID: 33908074
[TBL] [Abstract][Full Text] [Related]
18. The evolution of hypertension treatment in Belgium, a pharmacoepidemiological study.
Wolf M; Heuten HG; De Swaef A; de Falleur M; Verpooten GA
Acta Cardiol; 2012 Apr; 67(2):147-52. PubMed ID: 22641971
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensives and melanoma: An updated review.
Williams NM; Vincent LT; Rodriguez GA; Nouri K
Pigment Cell Melanoma Res; 2020 Nov; 33(6):806-813. PubMed ID: 32757474
[TBL] [Abstract][Full Text] [Related]
20. Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.
Marcum ZA; Li Y; Lee SJ; Steinman MA; Graham L; Jing B; Fung K; Peralta CA; Odden MC
J Alzheimers Dis; 2022; 86(3):1149-1158. PubMed ID: 35147539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
